Rifampicin in higher doses

Phase 2Completed

0 watching 0 views this week⚡ Active

Hype Score

Development Stage

✓

Pre-clinical

✓

Phase 1

Phase 2

Phase 3

Approved

Indication / Disease

Tuberculosis

Conditions

Tuberculosis

Trial Timeline

Jul 1, 2010 → Sep 1, 2013

NCT ID

NCT00760149

About Rifampicin in higher doses

Rifampicin in higher doses is a phase 2 stage product being developed by Sanofi for Tuberculosis. The current trial status is completed. This product is registered under clinical trial identifier NCT00760149. Target conditions include Tuberculosis.

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (1)

NCT ID	Phase	Status	Start	Completion	Indication
NCT00760149	Phase 2	Completed	Jul 1, 2010	Sep 1, 2013	Tuberculosis

Competing Products

20 competing products in Tuberculosis

See all competitors

Product	Company	Stage	Hype Score
GSK1349572 + Placebo + Iohexol Injection + Para-aminohippurate infusion	Shionogi	Phase 1	33
BCG Vaccine USP + Isoniazid + Rifampin	Merck	Phase 1	33
MK-7762 (TBD09)	Merck	Phase 1	33
Doravirine (DOR) + Rifapentine (RPT) + Isoniazid (INH)	Merck	Phase 1	33
Indacaterol + Control	Novartis	Phase 3	77
Ag85B-ESAT6 fusion protein H1 + Ag85B-ESAT6 fusion protein H1 + Ag85B-ESAT6 fusion protein H1 + Ag85B-ESAT6 fusion protein H1 + Ag85B-ESAT6 fusion protein H1 + Ag85B-ESAT6 fusion protein H1	Novartis	Phase 1	33
Delamanid + Levofloxacin + Bedaquiline + Clofazimine + Linezolid	Novartis	Phase 2	52
Rifampicin + Isoniazid + Pyrazinamide + Kanamycin + Moxifloxacin	Novartis	Phase 1	33
Rifapentine daily + Rifapentine weekly	Gilead Sciences	Approved	84
rifabutin	Pfizer	Pre-clinical	22
Linezolid + Ethambutol	Pfizer	Phase 2	51
Myrin© 2 (Rifampicin + Isoniazid) + Rimactane® (Rifampicin)	Pfizer	Phase 1	32
Azacitidine Injection	Bristol Myers Squibb	Phase 1/2	40
Rifapentine + Isoniazid	Sanofi	Phase 1/2	40
AERAS-404 + Placebo + Bacillus Calmette-Guérin (BCG)	Sanofi	Phase 2	51
rifampin + rifapentine + rifapentine + rifapentine	Sanofi	Phase 2	51
rifapentine (M000473) + EFZ EMT TDF	Sanofi	Phase 1	32
Moxifloxacin, Ethambutol, Isoniazid, Pyrazinamide & Rifampicin	Sanofi	Phase 3	76
Higher-Dose Rifampin	Sanofi	Phase 2	51
Rifampin & midazolam + rifapentine & midazolam + rifapentine & midazolam + rifapentine & midazolam + rifapentine and midazolam + rifapentine and midazolam	Sanofi	Phase 1	32

Other Products from Sanofi

Adacel®Approved

LACTIC ACID(ND)Approved

DupilumabApproved

glatiramer acetateApproved

INSULIN GLULISINE + INSULIN GLARGINEApproved